Taylor Swift’s “Patient Zero” launches at No. 1 on both the Billboard Global 200 and Billboard Global Excl. U.S. charts.
The single is Swift’s eighth Global 200 leader — tying her with BTS for the most since the chart began in September 2020. She adds her fifth Global Excl. U.S. No. 1, breaking out of a tie with Bad Bunny and Ariana Grande for the most among soloists; BTS leads all acts with eight.
Related
Taylor Swift’s ‘The Life of a Showgirl’ Returns to No. 1 on Billboard 200 After ‘Encore’ Reissue
Taylor Swift’s ‘Patient Zero’ Debuts at No. 1 on Billboard Hot 100
Taylor Swift Earns U.K. Chart Double as ‘Patient Zero’ & ‘The Life of a Showgirl’ Hit No. 1
“Patient Zero” is one of four new songs on the deluxe version, released Sept. 25, of Swift’s 2025 album, The Life of a Showgirl, dubbed The Life of a Showgirl: The Encore. The set (all versions combined) bounds back to No. 1 for a 13th week atop the United States-based Billboard 200 chart while its three other new tracks arrive in the top 10 of both global rankings: “Cleveland!,” “Babylon” and “Pink Clouding.”
“Patient Zero” opens as the biggest song in the world with 70.7 million streams and 80,000 sold globally Sept. 25-Oct. 1, according to Luminate. The song’s Swift-directed video, starring Swift, Dakota Johnson and Colin Farrell, premiered Sept. 27 during the 2026 MTV Video Music Awards.
“Cleveland!” rocks onto the Global 200 at No. 2, led by 37.3 million U.S. streams worldwide, followed by “Babylon” at No. 3 (36.3 million) and “Pink Clouding” at No. 5 (36 million). Now up to 47 top 10s, Swift passes Drake (45) for the most in the chart’s archives.
Plus, Swift’s “The Fate of Ophelia” rebounds 14-8 on the Global 200 (29.8 million, up 27%). Released on the initial version of The Life of a Showgirl, it spent seven weeks at No. 1 last October through February.
“Patient Zero” totaled 37.3 million streams and sold 15,000 outside the U.S. in the tracking week. “Cleveland!” is new at No. 6 on Global Excl. U.S., followed by “Pink Clouding” at No. 7 and “Babylon” at No. 8. Swift extends her mark for the most top 10s on the tally to 34; Bad Bunny ranks second with 24. Additionally, “The Fate of Ophelia” rises 13-10 after eight frames at No. 1 last October-February.
After four weeks at No. 1 on both the Global 200 and Global Excl. U.S., Karol G, Judeline and rusowsky’s “BbY WOW” dips to No. 3 on the former and No. 2 on the latter.
Elsewhere in the Global Excl. U.S. top five, Dua Lipa’s “Training Season” falls to No. 3 from its No. 2 best and ADÉLA again boasts two songs: “Nicole Kidman” rises 5-4 for a new high and “Ain’t in LA” recedes to No. 5 from its No. 4 peak.
The Billboard Global 200 and Global Excl. U.S. charts rank songs based on streaming and sales activity culled from more than 200 territories around the world, as compiled by Luminate. The Global 200 is inclusive of worldwide data and the Global Excl. U.S. chart comprises data from territories excluding the United States.
Chart ranks are based on a weighted formula incorporating official-only streams on both subscription and ad-supported tiers of audio and video music services, as well as download sales, the latter of which reflect purchases from full-service digital music retailers from around the world, with sales from direct-to-consumer (D2C) sites excluded from the charts’ calculations.
The latest charts, dated Oct. 10, 2026, will update on Billboard.com tomorrow, Oct. 6. For both tallies, the top 100 titles are available to all readers on Billboard.com, while the complete 200-title rankings are visible on Billboard Pro, Billboard’s subscription-based service. For all chart news, you can follow @billboard and @billboardcharts on both X, formerly known as Twitter, and Instagram.
Luminate, the independent data provider to the Billboard charts, completes a thorough review of all data submissions used in compiling the weekly chart rankings. Luminate reviews and authenticates data. In partnership with Billboard, data deemed suspicious or unverifiable is removed, using established criteria, before final chart calculations are made and published.